Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Purine is a heterocyclic aromatic organic compound consisting of a fused six-membered pyrimidine ring and a five-membered imidazole ring, totaling nine atoms (four nitrogens, five carbons). It forms the basic skeleton for nucleobases like adenine and guanine, essential components of DNA and RNA. Purines and their derivatives (including ATP, GTP, cAMP) play crucial roles in cellular bioenergetics, signal transduction, and serve as substrates for enzymes and receptors; they also function as neurotransmitters and secondary messengers in purinergic signaling pathways. While "purine" itself is not a pharmaceutical target, purinergic receptors and enzymes of purine metabolism are relevant drug targets in multiple diseases. If you require structured data for a therapeutic target, more precise entries would include "Adenosine receptor," "ATP synthase," or "Hypoxanthine-guanine phosphoribosyltransferase," rather than "Purine."
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Purine.